Human pluripotent stem cell culture: Considerations for maintenance, expansion, and therapeutics

Cell Stem Cell

Volumn 14, Issue 1, 2014, Pages 13-26

  Chen, Kevin G ^a   Mallon, Barbara S ^a   McKay, Ronald D G ^b   Robey, Pamela G ^c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b LIEBER INSTITUTE FOR BRAIN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIGEL; SCLEROPROTEIN;

BIOREACTOR; CELL AGGREGATION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL THERAPY; COCULTURE; CRYOPRESERVATION; CULTURE MEDIUM; CULTURE OPTIMIZATION; EXTRACELLULAR MATRIX; GENETIC ENGINEERING; HUMAN; INOCULATION; LARGE SCALE PRODUCTION; MICROENCAPSULATION; MICROFLUIDICS; MORPHOGENESIS; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SINGLE CELL ANALYSIS; STANDARDIZATION; STEM CELL CULTURE; STEM CELL EXPANSION; SURFACE PROPERTY; SUSPENSION CELL CULTURE; XENO-FREE CULTURE; CULTURE TECHNIQUE; CYTOLOGY; METHODOLOGY; TRANSPLANTATION;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; HUMANS; PLURIPOTENT STEM CELLS;

EID: 84896836202     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2013.12.005     Document Type: Review

References (104)

1. Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M., Andrews, P.W., Beighton, G., Bello, P.A., Benvenisty, N., Berry, L.S., Bevan, S., et al.; International Stem Cell Initiative (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat. Biotechnol. 25, 803-816.
2. Akopian, V., Andrews, P.W., Beil, S., Benvenisty, N., Brehm, J., Christie, M., Ford, A., Fox, V., Gokhale, P.J., Healy, L., et al.; International Stem Cell Initiative Consortium (2010). Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell. Dev. Biol. Anim. 46, 247-258.
3. Amit, M., Chebath, J., Margulets, V., Laevsky, I., Miropolsky, Y., Shariki, K., Peri, M., Blais, I., Slutsky, G., Revel, M., and Itskovitz-Eldor, J. (2010). Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Rev. 6, 248-259.
4. Andrews, P.W., Arias-Diaz, J., Auerbach, J., Alvarez, M., Ahrlund-Richter, L., Baker, D., Benvenisty, N., Ben-Josef, D., Blin, G., Borghese, L., et al.; International Stem Cell Banking Initiative (2009). Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev. 5, 301-314.
5. Androutsellis-Theotokis, A., Leker, R.R., Soldner, F., Hoeppner, D.J., Ravin, R., Poser, S.W., Rueger, M.A., Bae, S.K., Kittappa, R., and McKay, R.D. (2006). Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442, 823-826.
6. Baker, D.E., Harrison, N.J., Maltby, E., Smith, K., Moore, H.D., Shaw, P.J., Heath, P.R., Holden, H., and Andrews, P.W. (2007). Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25, 207-215.
7. Banerjee, I., Sharma, N., and Yarmush, M. (2011). Impact of co-culture on pancreatic differentiation of embryonic stem cells. J. Tissue Eng. Regen. Med. 5, 313-323.
8. Borstlap, J., Luong, M.X., Rooke, H.M., Aran, B., Damaschun, A., Elstner, A., Smith, K.P., Stein, G.S., and Veiga, A. (2010). International stem cell registries. In Vitro Cell. Dev. Biol. Anim. 46, 242-246.
9. Braam, S.R., Denning, C., Matsa, E., Young, L.E., Passier, R., and Mummery, C.L. (2008a). Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification. Nat. Protoc. 3, 1435-1443.
10. Braam, S.R., Denning, C., van den Brink, S., Kats, P., Hochstenbach, R., Passier, R., and Mummery, C.L. (2008b). Improved genetic manipulation of human embryonic stem cells. Nat. Methods 5, 389-392.
11. Braam, S.R., Zeinstra, L., Litjens, S., Ward-van Oostwaard, D., van den Brink, S., van Laake, L., Lebrin, F., Kats, P., Hochstenbach, R., Passier, R., et al. (2008c). Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells 26, 2257-2265.
12. Cameron, C.M., Hu, W.S., and Kaufman, D.S. (2006). Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol. Bioeng. 94, 938-948.
13. Chaddah, M.R., Dickie, B.G., Lyall, D., Marshall, C.J., Sykes, J.B., and Bruijn, L.I. (2011). Meeting report of the International Consortium of Stem Cell Networks' Workshop Towards Clinical Trials Using Stem Cells for Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Amyotroph. Lateral Scler. 12, 315-317.
14. Chan, Y.S., Göke, J., Ng, J.H., Lu, X., Gonzales, K.A., Tan, C.P., Tng, W.Q., Hong, Z.Z., Lim, Y.S., and Ng, H.H. (2013). Induction of a Human Pluripotent State with Distinct Regulatory Circuitry that Resembles Preimplantation Epiblast. Cell Stem Cell 13, 663-675.
15. Chen, A.K., Chen, X., Choo, A.B., Reuveny, S., and Oh, S.K. (2010a). Expansion of human embryonic stem cells on cellulose microcarriers. Curr. Protoc. Stem Cell Biol. Chapter 1, http://dx.doi.org/10.1002/9780470151808. sc01c11s14, Unit 1C 11.
16. Chen, G., Hou, Z., Gulbranson, D.R., and Thomson, J.A. (2010b). Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell 7, 240-248.
17. Chen, A.K., Chen, X., Choo, A.B., Reuveny, S., and Oh, S.K. (2011a). Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res. (Amst.) 7, 97-111.
18. Chen, G., Gulbranson, D.R., Hou, Z., Bolin, J.M., Ruotti, V., Probasco, M.D., Smuga-Otto, K., Howden, S.E., Diol, N.R., Propson, N.E., et al. (2011b). Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424-429.
19. Chen, K.G., Mallon, B.S., Hamilton, R.S., Kozhich, O.A., Park, K., Hoeppner, D.J., Robey, P.G., and McKay, R.D. (2012a). Non-colony type monolayer culture of human embryonic stem cells. Stem Cell Res. (Amst.) 9, 237-248.
20. Chen, V.C., Couture, S.M., Ye, J., Lin, Z., Hua, G., Huang, H.I., Wu, J., Hsu, D., Carpenter, M.K., and Couture, L.A. (2012b). Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res. (Amst.) 8, 388-402.
21. Cimetta, E., Figallo, E., Cannizzaro, C., Elvassore, N., and Vunjak-Novakovic, G. (2009). Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications. Methods 47, 81-89.
22. Crook, J.M., Peura, T.T., Kravets, L., Bosman, A.G., Buzzard, J.J., Horne, R., Hentze, H., Dunn, N.R., Zweigerdt, R., Chua, F., et al. (2007). The Generation of Six Clinical-Grade Human Embryonic Stem Cell Lines. Cell Stem Cell 1, 490-494.
23. Crook, J.M., Hei, D., and Stacey, G. (2010). The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on. In Vitro Cell. Dev. Biol. Anim. 46, 169-172.
24. Csaszar, E., Kirouac, D.C., Yu, M., Wang, W., Qiao, W., Cooke, M.P., Boitano, A.E., Ito, C., and Zandstra, P.W. (2012). Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell 10, 218-229.
25. Daley, G.Q. (2012). The promise and perils of stem cell therapeutics. Cell Stem Cell 10, 740-749.
26. Dang, S.M., Gerecht-Nir, S., Chen, J., Itskovitz-Eldor, J., and Zandstra, P.W. (2004). Controlled, scalable embryonic stem cell differentiation culture. Stem Cells 22, 275-282.
27. DeQuach, J.A., Mezzano, V., Miglani, A., Lange, S., Keller, G.M., Sheikh, F., and Christman, K.L. (2010). Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture. PLoS ONE 5, e13039.
28. Derda, R., Li, L., Orner, B.P., Lewis, R.L., Thomson, J.A., and Kiessling, L.L. (2007). Defined substrates for human embryonic stem cell growth identified from surface arrays. ACS Chem. Biol. 2, 347-355.
29. Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K., and Sasai, Y. (2008). Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3, 519-532.
30. Engle, S.J., and Puppala, D. (2013). Integrating human pluripotent stem cells into drug development. Cell Stem Cell 12, 669-677.
31. Ezashi, T., Das, P., and Roberts, R.M. (2005). Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. USA 102, 4783-4788.
32. Fernandes, A.M., Marinho, P.A., Sartore, R.C., Paulsen, B.S., Mariante, R.M., Castilho, L.R., and Rehen, S.K. (2009). Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz. J. Med. Biol. Res. 42, 515-522.
33. Fok, E.Y., and Zandstra, P.W. (2005). Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells 23, 1333-1342.
34. Forsyth, N.R., Musio, A., Vezzoni, P., Simpson, A.H., Noble, B.S., and McWhir, J. (2006). Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells 8, 16-23.
35. Gafni, O., Weinberger, L., Mansour, A.A., Manor, Y.S., Chomsky, E., Ben- Yosef, D., Kalma, Y., Viukov, S., Maza, I., Zviran, A., et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282-286.
36. Genbacev, O., Krtolica, A., Zdravkovic, T., Brunette, E., Powell, S., Nath, A., Caceres, E., McMaster, M., McDonagh, S., Li, Y., et al. (2005). Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. Fertil. Steril. 83, 1517-1529.
37. Gerecht-Nir, S., Cohen, S., and Itskovitz-Eldor, J. (2004). Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol. Bioeng. 86, 493-502.
38. Hanna, J.H., Saha, K., and Jaenisch, R. (2010). Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143, 508-525.
39. Heng, B.C., Li, J., Chen, A.K., Reuveny, S., Cool, S.M., Birch, W.R., and Oh, S.K. (2012). Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectincoated surfaces. Stem Cells Dev. 21, 1701-1715.
40. James, D., Levine, A.J., Besser, D., and Hemmati-Brivanlou, A. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132, 1273-1282.
41. Kleinman, H.K., McGarvey, M.L., Liotta, L.A., Robey, P.G., Tryggvason, K., and Martin, G.R. (1982). Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21, 6188-6193.
42. Kleinman, H.K., McGarvey, M.L., Hassell, J.R., and Martin, G.R. (1983). Formation of a supramolecular complex is involved in the reconstitution of basement membrane components. Biochemistry 22, 4969-4974.
43. Kolhar, P., Kotamraju, V.R., Hikita, S.T., Clegg, D.O., and Ruoslahti, E. (2010). Synthetic surfaces for human embryonic stem cell culture. J. Biotechnol. 146, 143-146.
44. Krawetz, R., Taiani, J.T., Liu, S., Meng, G., Li, X., Kallos, M.S., and Rancourt, D.E. (2010). Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng. Part C Methods 16, 573-582.
45. Kunova, M., Matulka, K., Eiselleova, L., Salykin, A., Kubikova, I., Kyrylenko, S., Hampl, A., and Dvorak, P. (2013). Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viability. Stem Cells Transl Med 2, 246-254.
46. Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles, M.E., Homfray, T., Penninger, J.M., Jackson, A.P., and Knoblich, J.A. (2013). Cerebral organoids model human brain development and microcephaly. Nature 501, 373-379.
47. Lecina, M., Ting, S., Choo, A., Reuveny, S., and Oh, S. (2010). Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng. Part C Methods 16, 1609-1619.
48. Lee, A.S., Tang, C., Rao, M.S., Weissman, I.L., and Wu, J.C. (2013). Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat. Med. 19, 998-1004.
49. Leung, H.W., Chen, A., Choo, A.B., Reuveny, S., and Oh, S.K. (2011). Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng. Part C Methods 17, 165-172.
50. Li, Y., Powell, S., Brunette, E., Lebkowski, J., and Mandalam, R. (2005). Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol. Bioeng. 91, 688-698.
51. Li, L., Klim, J.R., Derda, R., Courtney, A.H., and Kiessling, L.L. (2011). Spatial control of cell fate using synthetic surfaces to potentiate TGF-beta signaling. Proc. Natl. Acad. Sci. USA 108, 11745-11750.
52. Liang, G., and Zhang, Y. (2013). Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13, 149-159.
53. Liew, C.G., Draper, J.S., Walsh, J., Moore, H., and Andrews, P.W. (2007). Transient and stable transgene expression in human embryonic stem cells. Stem Cells 25, 1521-1528.
54. Lock, L.T., and Tzanakakis, E.S. (2009). Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirredsuspension culture. Tissue Eng. Part A 15, 2051-2063.
55. Ludwig, T.E., Levenstein, M.E., Jones, J.M., Berggren, W.T., Mitchen, E.R., Frane, J.L., Crandall, L.J., Daigh, C.A., Conard, K.R., Piekarczyk, M.S., et al. (2006). Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187.
56. Mackay, A.R., Gomez, D.E., Cottam, D.W., Rees, R.C., Nason, A.M., and Thorgeirsson, U.P. (1993). Identification of the 72-kDa (MMP-2) and 92-kDa (MMP-9) gelatinase/type IV collagenase in preparations of laminin and Matrigel. Biotechniques 15, 1048-1051.
57. Malchenko, S., Galat, V., Seftor, E.A., Vanin, E.F., Costa, F.F., Seftor, R.E., Soares, M.B., and Hendrix, M.J. (2010). Cancer hallmarks in induced pluripotent cells: new insights. J. Cell. Physiol. 225, 390-393.
58. Mallon, B.S., Park, K.Y., Chen, K.G., Hamilton, R.S., and McKay, R.D. (2006). Toward xeno-free culture of human embryonic stem cells. Int. J. Biochem. Cell Biol. 38, 1063-1075.
59. Melkoumian, Z., Weber, J.L., Weber, D.M., Fadeev, A.G., Zhou, Y., Dolley-Sonneville, P., Yang, J., Qiu, L., Priest, C.A., Shogbon, C., et al. (2010). Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat. Biotechnol. 28, 606-610.
60. Moledina, F., Clarke, G., Oskooei, A., Onishi, K., Günther, A., and Zandstra, P.W. (2012). Predictive microfluidic control of regulatory ligand trajectories in individual pluripotent cells. Proc. Natl. Acad. Sci. USA 109, 3264-3269.
61. Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A.B., et al. (2003). Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733-2740.
62. Murua, A., Portero, A., Orive, G., Hernández, R.M., de Castro, M., and Pedraz, J.L. (2008). Cell microencapsulation technology: towards clinical application. J. Control. Release 132, 76-83.
63. Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M., and Sasai, Y. (2012). Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10, 771-785.
64. Nichols, J., and Smith, A. (2009). Naive and primed pluripotent states. Cell Stem Cell 4, 487-492.
65. Nie, Y., Bergendahl, V., Hei, D.J., Jones, J.M., and Palecek, S.P. (2009). Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol. Prog. 25, 20-31.
66. Niebruegge, S., Bauwens, C.L., Peerani, R., Thavandiran, N., Masse, S., Sevaptisidis, E., Nanthakumar, K., Woodhouse, K., Husain, M., Kumacheva, E., and Zandstra, P.W. (2009). Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygencontrolled bioreactor. Biotechnol. Bioeng. 102, 493-507.
67. Oh, S.K., Chen, A.K., Mok, Y., Chen, X., Lim, U.M., Chin, A., Choo, A.B., and Reuveny, S. (2009). Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. (Amst.) 2, 219-230.
68. Ohgushi, M., Matsumura, M., Eiraku, M., Murakami, K., Aramaki, T., Nishiyama, A., Muguruma, K., Nakano, T., Suga, H., Ueno, M., et al. (2010). Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7, 225-239.
69. Padmanabhan, R., Chen, K.G., Gillet, J.P., Handley, M., Mallon, B.S., Hamilton, R.S., Park, K., Varma, S., Mehaffey, M.G., Robey, P.G., et al. (2012). Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells. Stem Cells 30, 2175-2187.
70. Panchision, D.M. (2013). Meeting report: using stem cells for biological and therapeutics discovery in mental illness, April 2012. Stem Cells Transl Med 2, 217-222.
71. Phillips, B.W., Horne, R., Lay, T.S., Rust, W.L., Teck, T.T., and Crook, J.M. (2008). Attachment and growth of human embryonic stem cells on microcarriers. J. Biotechnol. 138, 24-32.
72. Pistollato, F., Bremer-Hoffmann, S., Healy, L., Young, L., and Stacey, G. (2012). Standardization of pluripotent stem cell cultures for toxicity testing. Expert Opin. Drug Metab. Toxicol. 8, 239-257.
73. Rao, M. (2013). iPSC-Based Cell Therapy: An Important Step Forward. Stem Cell Reports 1, 281-282.
74. Richards, M., Fong, C.Y., Chan, W.K., Wong, P.C., and Bongso, A. (2002). Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20, 933-936.
75. Rodin, S., Domogatskaya, A., Ström, S., Hansson, E.M., Chien, K.R., Inzunza, J., Hovatta, O., and Tryggvason, K. (2010). Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol. 28, 611-615.
76. Saha, K., Mei, Y., Reisterer, C.M., Pyzocha, N.K., Yang, J., Muffat, J., Davies, M.C., Alexander, M.R., Langer, R., Anderson, D.G., and Jaenisch, R. (2011). Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proc. Natl. Acad. Sci. USA 108, 18714-18719.
77. Sasai, Y. (2013). Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. Cell Stem Cell 12, 520-530.
78. Serra, M., Correia, C., Malpique, R., Brito, C., Jensen, J., Bjorquist, P., Carrondo, M.J., and Alves, P.M. (2011). Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS ONE 6, e23212.
79. Serra, M., Brito, C., Correia, C., and Alves, P.M. (2012). Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 30, 350-359.
80. Siti-Ismail, N., Bishop, A.E., Polak, J.M., and Mantalaris, A. (2008). The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 29, 3946-3952.
81. Stacey, G.N., Crook, J.M., Hei, D., and Ludwig, T. (2013). Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells? Cell Stem Cell 13, 385-388.
82. Steiner, D., Khaner, H., Cohen, M., Even-Ram, S., Gil, Y., Itsykson, P., Turetsky, T., Idelson, M., Aizenman, E., Ram, R., et al. (2010). Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat. Biotechnol. 28, 361-364.
83. Stewart, M.H., Bossé, M., Chadwick, K., Menendez, P., Bendall, S.C., and Bhatia, M. (2006). Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat. Methods 3, 807-815.
84. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
85. Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.R., Ueno, Y., Zheng, Y.W., Koike, N., et al. (2013). Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481-484.
86. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., and Jones, J.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
87. Tsutsui, H., Valamehr, B., Hindoyan, A., Qiao, R., Ding, X., Guo, S., Witte, O.N., Liu, X., Ho, C.M., and Wu, H. (2011). An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells. Nat Commun 2, 167.
88. Turner, M., Leslie, S., Martin, N.G., Peschanski, M., Rao, M., Taylor, C.J., Trounson, A., Turner, D., Yamanaka, S., and Wilmut, I. (2013). Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell 13, 382-384.
89. Ungrin, M.D., Joshi, C., Nica, A., Bauwens, C., and Zandstra, P.W. (2008). Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One 3, e1565.
90. Vallier, L., Alexander, M., and Pedersen, R.A. (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509.
91. van der Meer, A.D., Orlova, V.V., ten Dijke, P., van den Berg, A., and Mummery, C.L. (2013). Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. Lab Chip 13, 3562-3568.
92. Villa-Diaz, L.G., Torisawa, Y.S., Uchida, T., Ding, J., Nogueira-de-Souza, N.C., O'Shea, K.S., Takayama, S., and Smith, G.D. (2009). Microfluidic culture of single human embryonic stem cell colonies. Lab Chip 9, 1749-1755.
93. Villa-Diaz, L.G., Nandivada, H., Ding, J., Nogueira-de-Souza, N.C., Krebsbach, P.H., O'Shea, K.S., Lahann, J., and Smith, G.D. (2010). Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat. Biotechnol. 28, 581-583.
94. Vukicevic, S., Kleinman, H.K., Luyten, F.P., Roberts, A.B., Roche, N.S., and Reddi, A.H. (1992). Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp. Cell Res. 202, 1-8.
95. Wang, G., Zhang, H., Zhao, Y., Li, J., Cai, J., Wang, P., Meng, S., Feng, J., Miao, C., Ding, M., et al. (2005). Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem. Biophys. Res. Commun. 330, 934-942.
96. Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J.B., Nishikawa, S., Nishikawa, S., Muguruma, K., and Sasai, Y. (2007). A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681-686.
97. Xiao, L., Yuan, X., and Sharkis, S.J. (2006). Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells 24, 1476-1486.
98. Xu, C., Inokuma, M.S., Denham, J., Golds, K., Kundu, P., Gold, J.D., and Carpenter, M.K. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971-974.
99. Xu, R.H., Peck, R.M., Li, D.S., Feng, X., Ludwig, T., and Thomson, J.A. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2, 185-190.
100. Ying, Q.L., Nichols, J., Chambers, I., and Smith, A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell selfrenewal in collaboration with STAT3. Cell 115, 281-292.
101. Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., and Smith, A. (2008). The ground state of embryonic stem cell self-renewal. Nature 453, 519-523.
102. Yirme, G., Amit, M., Laevsky, I., Osenberg, S., and Itskovitz-Eldor, J. (2008). Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev. 17, 1227-1241.
103. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
104. Zweigerdt, R., Olmer, R., Singh, H., Haverich, A., and Martin, U. (2011). Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 6, 689-700.